Navigation Links
Landauer, Inc. Reports Fiscal 2013 Third Quarter Results
Date:8/5/2013

e incurred in the prior period and service cost reductions of $0.3 million.

During the third quarter of 2013, it became apparent that anticipated revenue trends in our Medical Products reporting unit were not being achieved to the extent forecasted.  Early budget reviews also indicated future sales growth may be less than expected.  We updated the forecasted results of operations for our Medical Products operating segment based on the most recent financial results and our best estimates of future operations. The updated forecast reflects a slower growth in revenues for the Medical Products segment due to anticipated continued pricing pressures from certain competitors greater than the anticipated growth from existing and new product sales.
We recorded a $22.7 million pretax charge for the impairment of goodwill to reduce the carrying value of goodwill in our Medical Products segment. The impairment charge is non-cash in nature and does not affect the Company's liquidity or debt covenant compliance.

Operating loss for the third fiscal quarter of 2013 was $16.8 million, a decrease of $26.0 million, compared with operating income of $9.2 million for the third fiscal quarter of 2012. Operating income, adjusted for the goodwill impairment charge for the third fiscal quarter of 2013, was $6.9 million.

The effective tax rate for the third fiscal quarter of 2013 and 2012 was 21.6% and 23.0%, respectively. The decrease in the effective tax rate was due primarily to benefits from U.S. foreign tax credits.  Without impairment of goodwill the effective tax rate would have been 20.9% for the third fiscal quarter of 2013, a decline over the prior year's tax rate due primarily to benefits from U.S. foreign tax credits.

Net loss for the third fiscal quarter ended June 30, 2013 was $13.8 million, or $1.46 per diluted share, compared to net income of $6.6 million, or $0.69 per diluted share, in the same period last year. The decrease in n
'/>"/>

SOURCE Landauer, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Landauer, Inc. Declares Regular Cash Dividend
2. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
3. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Second Quarter 2013 Results
4. Landauer, Inc. Reports Fiscal 2013 First Quarter Results
5. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
6. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
7. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
8. Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
9. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
10. PDI Reports 2013 Second Quarter Financial Results
11. U.S. Orthopedic Biomaterials Market & Global Biomaterials Industry Reviewed by Products and Applications in New Research Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BRUSSELS , Sept. 1, 2015 ... (Euronext Brussels: UCB) today announced top-line results from ... Compared with Teriparatide in postmenopaUsal women with osteoporosis ... bisphosphonatE therapy). The study (NCT01796301) met the primary ... of romosozumab in the percent change of total ...
(Date:9/1/2015)... Konica Minolta Medical Imaging announced today the ... to deliver enterprise level imaging to community hospitals, clinics ... as the Konica Minolta AeroDR wireless flat panel detector, ... CR to DR. The SIGMA II CS-7s CR system ... unparalleled reliability and high capacity to help maximize patient ...
(Date:9/1/2015)... DALLAS , Sept. 1, 2015 UT ... and distinguished faculty members joined U.S. Representatives ... in a roundtable discussion on the 21 st ... biomedical research currently being considered by the ... faculty – including National Academy of Sciences members, department ...
Breaking Medicine Technology:Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 4U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 5
... MacroChem Corporation (OTC,Bulletin Board: MACM) today announced results ... who completed a 48-week, U.S. multi-center,open-label efficacy and ... the treatment of onychomycosis (nail fungus). The composite,primary ... defined as,negative mycology (negative fungal culture and negative ...
... Sound Pharmaceuticals (SPI) has filed,an Investigational New ... of a proprietary formulation of ebselen for the ... oral capsule,containing ebselen, SPI-3005, will be tested in ... patients receiving platinum based chemotherapy.,This marks the second ...
Cached Medicine Technology:MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2
(Date:9/2/2015)... ... September 02, 2015 , ... Ovarian cancer continues to be the ... of getting ovarian cancer in her lifetime is approximately 1 in 75. This year ... cancer, and 14,000 will die. , There is no test to detect ovarian ...
(Date:9/2/2015)... ... September 02, 2015 , ... Lakeview Health, a ... to International Overdose Awareness Day. The goal is to provide people information regarding ... so that they may get help. , Lakeview Health will be ...
(Date:9/2/2015)... ... September 02, 2015 , ... Available ... marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream , an evolution ... biotechnological anti-aging power with a lipid-replenishing marine oil for intense nourishing and moisturizing. ...
(Date:9/2/2015)... ... 2015 , ... Please join the world renowned Brain Aneurysm ... established by the Foundation in 2007 with the help of Massachusetts State Representative ... remains our top priority,” commented Christine Buckley, Executive Director of the Brain Aneurysm ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy Partners, a ... to the Inc. 5000 List, an independent ranking of the fastest- growing ... years, and this achievement puts Canopy in rarefied company. Over the years, this ...
Breaking Medicine News(10 mins):Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:August 31 is International Overdose Awareness Day – Lakeview Health to Help Bring Awareness 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2
... can do well with stress busters. According to a world ... Taiwan on top of the list. China, the Philippines,// Botswana, ... their ranks on the “Stressed Out” Statistics. ,Businessmen ... 7000 businessmen from 30 countries were observed , amongst them ...
... Yoga guru Ramdev signed agreements with the Jharkhand government to ... of herbal plants.// ,The memorandums of understanding were signed ... ,Announcing government aid of Rs.10 million for the ... Jharkhand as a herbal state that can benefit the common ...
... University researcher Chensheng "Alex" Lu, PhD, 'Organic diets lower ... U.S. agricultural production.'// ,The fact is ... items. The result was that concentration of pesticides was ... by Dr. Lu, "The use of organophosphorus pesticides in ...
... to you readers but if new research is to be believed ... ,This revelation comes from American scientists who found that the ... by way of an increase the number of nerve connections in ... ,The Yale University is credited with the study and it ...
... Epidemiology Unit Director Dr Nihal Abeysinghe said that the country ... This is due to the result of the confirmation of ... are requesting the public to avoid importing poultry products from ... not contained by the Indian authorities then there is an ...
... of anabolic steroids, more specifically anabolic androgen steroid (AAS) ... sebaceous glands. Sebaceous glands present in the skin // ... of the body surface. ,Anabolic steroids are ... to treat unwanted weight loss in patients with HIV. ...
Cached Medicine News:Health News:Bird flu affects the export of poultry products to Sri Lanka and Nepal 2
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
Medicine Products: